TF
ABMD

TIAA FSB’s Abiomed Inc ABMD Stock Holding History

TIAA FSB’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,017
Closed -$250K – 590
2022
Q3 		$250K Sell
1,017
-2
-0.2% -$540 ﹤0.01% 505
2022
Q2 		$252K Buy
+1,019
New +$275K ﹤0.01% 516
2018
Q1 		– Sell
-11,861
Closed -$2.22M – 394
2017
Q4 		$2.22M Sell
11,861
-398
-3% -$74.3K 0.01% 235
2017
Q3 		$2.07M Hold
12,259
– – 0.01% 241
2017
Q2 		$1.76M Buy
+12,259
New +$1.65M 0.01% 246

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIAA FSB's ABMD Position: Q4 2022 in Review

TIAA FSB sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,017 shares — an estimated $250K sold.

TIAA FSB first reported a position in ABMD in Q2 2017 and held it in 5 quarters. The position peaked at $2.22M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • TIAA FSB reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • TIAA FSB sold 1,017 Abiomed Inc shares in Q4 2022, an estimated $250K.
  • TIAA FSB first reported a position in Abiomed Inc in Q2 2017 and held it in 5 quarters.
  • TIAA FSB's Abiomed Inc position peaked at $2.22M in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on TIAA FSB's 13F filing for Q4 2022, filed 12 Jan 2023.